Inheriting a Parents 401k Could Trigger a 25 IRS Penalty Key Withdrawal Rules to Know Tesla Chases Autonomous Driving Future While Stock Trades at 350x Earnings Healthcare and Tech Lead SP 500 to Modest Gains as Communication Services Lags Retail Investors Gain Direct Access to SpaceX IPO Through Major Brokerage Platforms Adani Enterprises Among Eight Stocks Reaching 52Week Highs Rallying Up to 30 in Past Month Jobless Claims Hold at Low Levels Signaling Continued Labor Market Resilience Polar Power Inc POLA Q1 2026 Earnings Net Loss of 005 Per Share Shares Fall 57 Amid Thin Disclosure BHP Q1 2026 Earnings EPS Misses Estimates Amid Cost and Commodity Pressures Dogwood Therapeutics Inc DWTX Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Focuses on Pipeline Progress DCOMP Q1 2026 Earnings EPS Misses Estimates Stock Flat HASI Q1 2026 Earnings EPS Beats Estimates by Double Digits Amid Steady Operational Performance IAC Q1 2026 Earnings WiderThanExpected Loss but Shares Rise Arcus Biosciences RCUS Edges Higher Amid Sector Momentum Key Support and Resistance Levels to Watch Qualys Inc QLYS Rises Over 2 as Cybersecurity Stock Tests Key Resistance Near 105 Viewbix Inc VBIX Consolidates at 364 Key Levels in Focus Kymera Therapeutics KYMR Slips Modestly While Holding Above Key Support BristolMyers Squibb BMY Declines 218 Support Levels in Focus as Stock Holds Above 55 Billie Eilishs Hit Me Hard and Soft Achieves Major Chart Milestone Amid Concert Film Success Consumer Sentiment Hits Record Low in May Amid Iran WarDriven Gas Price Surge SpaceX Delays Starship Launch Amid Plans for RecordBreaking Share Sale Indian Equity Indices Surge Over 1 as Crude Oil Prices Fall on USIran Deal Hopes Eicher Motors Among Top Gainers BristolMyers Squibb Taps AI Partnership with Anthropic as Hedge Funds Eye Its 425 Dividend Yield Twist Bioscience Expands Clonal Gene Portfolio to Include Long and Complex DNA Sequences Gold Surges 16 as Iran Deal Prospects Ease Inflation Concerns ASAN Q1 2026 Earnings EPS Beats Estimates by 116 Stock Declines 26 Jasper Therapeutics JSPR Edges Higher as Stock Tests Key Resistance Near 096